FdaApplication
ANDA 215825
Identifiers
- fda_app_no: ANDA215825
Properties
| Property | Value |
|---|---|
| applicant_name | XIROMED PHARMA ESPANA SL |
| application_type | ANDA |
| approval_date | 2022-04-21 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EPHEDRINE SULFATE | EPHEDRINE SULFATE | 50MG/ML (50MG/ML) | SOLUTION;INTRAVENOUS |
1 product